Skip to main content
Erschienen in: Cancer Causes & Control 4/2008

01.05.2008 | Original Paper

Alcohol, marijuana, and tobacco use patterns among youth in Canada

verfasst von: Scott Thomas Leatherdale, David Hammond, Rashid Ahmed

Erschienen in: Cancer Causes & Control | Ausgabe 4/2008

Einloggen, um Zugang zu erhalten

Abstract

The authors characterized changes in the prevalence of alcohol, tobacco, and marijuana use over time, and examined age of onset, co-morbid use and sociodemographic factors associated with ever using alcohol, tobacco, or marijuana in a nationally representative sample of Canadian youth. Data were collected from students in grades 7–9 as part of the Canadian Youth Smoking Survey (n = 19,018 in 2002; n = 29,243 in 2004). Descriptive analyses examined age of onset, co-morbid substance use and changes over time. Logistic regression models were used to examine factors associated with ever trying alcohol, tobacco, or marijuana with the 2004 data. Alcohol was the most prevalent substance used by youth and it was also the only substance which exhibited increased rates of use between 2002 and 2004. Co-morbid substance use was common, and it was rare to find youth who had used marijuana or tobacco without also having tried alcohol. As expected, youth who had poorer school performance were more likely to drink and smoke marijuana or tobacco, as were youth with more disposable income. Such timely and relevant data are important for guiding future policy, programing, and surveillance activities.
Fußnoten
1
The actual ages of initiation may even be younger than eight years of age given that our measure for age of initiation had a lower anchor of 8 years of age.
 
Literatur
1.
Zurück zum Zitat Nutt D, King LA, Saulsbury W, Blakemore C (2007) Development of a rational scale to asses the harm of drugs of potential misuse. Lancet 369:1047–1053PubMedCrossRef Nutt D, King LA, Saulsbury W, Blakemore C (2007) Development of a rational scale to asses the harm of drugs of potential misuse. Lancet 369:1047–1053PubMedCrossRef
2.
Zurück zum Zitat Rehm J, Taylor B, Room R (2006) Global burden of disease from alcohol, illicit drugs and tobacco. Drug Alcohol Rev 25:503–513PubMedCrossRef Rehm J, Taylor B, Room R (2006) Global burden of disease from alcohol, illicit drugs and tobacco. Drug Alcohol Rev 25:503–513PubMedCrossRef
4.
Zurück zum Zitat Colditz G, DeJong W, Hunter D, Trichopoulos D, Willett W (1996) Harvard report on cancer prevention. Volume 1: Causes of Human Cancer. Cancer Causes Control 7:S3–S58CrossRef Colditz G, DeJong W, Hunter D, Trichopoulos D, Willett W (1996) Harvard report on cancer prevention. Volume 1: Causes of Human Cancer. Cancer Causes Control 7:S3–S58CrossRef
5.
Zurück zum Zitat Adlaf EM, Begin P, Sawka E (eds) (2005) Canadian Addiction Survey (CAS): a national survey of Canadians’ use of alcohol and other drugs: prevalence of use and related harms: Detailed Report. Canadian Centre on Substance Abuse, Ottawa Adlaf EM, Begin P, Sawka E (eds) (2005) Canadian Addiction Survey (CAS): a national survey of Canadians’ use of alcohol and other drugs: prevalence of use and related harms: Detailed Report. Canadian Centre on Substance Abuse, Ottawa
7.
8.
Zurück zum Zitat Myers MG, Kelly JF (2006) Cigarette smoking among adolescents with alcohol and other drug use problems. Alcohol Res Health 29:221–227PubMed Myers MG, Kelly JF (2006) Cigarette smoking among adolescents with alcohol and other drug use problems. Alcohol Res Health 29:221–227PubMed
9.
Zurück zum Zitat Centers for Disease Control and Prevention (2004) Surveillance Summaries, May 21, 2004. MMWR 53:SS-2 Centers for Disease Control and Prevention (2004) Surveillance Summaries, May 21, 2004. MMWR 53:SS-2
10.
Zurück zum Zitat Adlaf EM, Paglia A (2005) Drug use among Ontario Students 1977–2005: OSDUS highlights. Centre for Addiction and Mental Health, Toronto Adlaf EM, Paglia A (2005) Drug use among Ontario Students 1977–2005: OSDUS highlights. Centre for Addiction and Mental Health, Toronto
11.
Zurück zum Zitat Leatherdale ST, Hammond D, Kaiserman M, Ahmed R (2007) Marijuana use among young adult smokers and non-smokers in Canada: are they smoking what we think they are smoking? Cancer Causes Control 18:391–397PubMedCrossRef Leatherdale ST, Hammond D, Kaiserman M, Ahmed R (2007) Marijuana use among young adult smokers and non-smokers in Canada: are they smoking what we think they are smoking? Cancer Causes Control 18:391–397PubMedCrossRef
13.
Zurück zum Zitat Health Canada (2002) Youth Smoking Survey Technical Report. Minister of Supply and Services Canada, Ottawa (2005) (Catalogue No. H46-1/44-2002E) Health Canada (2002) Youth Smoking Survey Technical Report. Minister of Supply and Services Canada, Ottawa (2005) (Catalogue No. H46-1/44-2002E)
14.
Zurück zum Zitat SAS Institute Inc (2001) The SAS System for Windows. Cary, NC: SAS Institute Inc. SAS Institute Inc (2001) The SAS System for Windows. Cary, NC: SAS Institute Inc.
15.
Zurück zum Zitat Poulin C, Elliot D (1997) Alcohol, tobacco and cannabis use among Nova Scotia adolescents: implications for prevention and harm reduction. CMAJ 156:1387–1393PubMed Poulin C, Elliot D (1997) Alcohol, tobacco and cannabis use among Nova Scotia adolescents: implications for prevention and harm reduction. CMAJ 156:1387–1393PubMed
16.
Zurück zum Zitat Boyle MH, Offord DR (1986) Smoking, drinking and use of illicit drugs among adolescents in Ontario: prevalence, patterns of use and sociodemographic correlates. CMAJ 135:1113–1121PubMed Boyle MH, Offord DR (1986) Smoking, drinking and use of illicit drugs among adolescents in Ontario: prevalence, patterns of use and sociodemographic correlates. CMAJ 135:1113–1121PubMed
17.
Zurück zum Zitat U.S. Department of Health and Human Services (1994) Preventing tobacco use among young people: a report of the surgeon general. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office of Smoking and Health, Atlanta, GA U.S. Department of Health and Human Services (1994) Preventing tobacco use among young people: a report of the surgeon general. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office of Smoking and Health, Atlanta, GA
18.
Zurück zum Zitat Rehm J, Room R, Graham K, Montinero M, Gmel G, Sempos CT (2003) The relationship of average volume of alcohol consumption and patterns of drinking to burden of disease – an overview. Addiction 98:1209–1228PubMedCrossRef Rehm J, Room R, Graham K, Montinero M, Gmel G, Sempos CT (2003) The relationship of average volume of alcohol consumption and patterns of drinking to burden of disease – an overview. Addiction 98:1209–1228PubMedCrossRef
19.
Zurück zum Zitat Centers for Disease Control and Prevention (1999) Best practices for comprehensive tobacco control programs—August 1999. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA, August, 1999 Centers for Disease Control and Prevention (1999) Best practices for comprehensive tobacco control programs—August 1999. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA, August, 1999
20.
Zurück zum Zitat Kandel DB (ed) (2002) Stages and pathways of drug involvement: examining the gateway hypothesis. Cambridge University Press, New York Kandel DB (ed) (2002) Stages and pathways of drug involvement: examining the gateway hypothesis. Cambridge University Press, New York
21.
Zurück zum Zitat Patton GC, Coffey C, Carlin JB, Sawyer SM, Lynskey M (2005) Reverse gateways? Frequent cannabis use as a predictor of tobacco initiation and nicotine dependence. Addiction 100:1518–1525PubMedCrossRef Patton GC, Coffey C, Carlin JB, Sawyer SM, Lynskey M (2005) Reverse gateways? Frequent cannabis use as a predictor of tobacco initiation and nicotine dependence. Addiction 100:1518–1525PubMedCrossRef
22.
Zurück zum Zitat Hall W (2006) Cannabis use and the mental health of young people. Aust N Z J Psychiatry 40:105–113PubMedCrossRef Hall W (2006) Cannabis use and the mental health of young people. Aust N Z J Psychiatry 40:105–113PubMedCrossRef
23.
Zurück zum Zitat Chaloupka FJ, Grossman M, Saffer H (2002) The effect of price on alcohol consumption and alcohol-related problems. Alcohol Res Health 26:22–34PubMed Chaloupka FJ, Grossman M, Saffer H (2002) The effect of price on alcohol consumption and alcohol-related problems. Alcohol Res Health 26:22–34PubMed
24.
Zurück zum Zitat Chaloupka FJ (1999) Macro-social influences: the effects of prices and tobacco-control policies on the demand for tobacco products. Nicotine Tob Res 1:S105–S109PubMedCrossRef Chaloupka FJ (1999) Macro-social influences: the effects of prices and tobacco-control policies on the demand for tobacco products. Nicotine Tob Res 1:S105–S109PubMedCrossRef
Metadaten
Titel
Alcohol, marijuana, and tobacco use patterns among youth in Canada
verfasst von
Scott Thomas Leatherdale
David Hammond
Rashid Ahmed
Publikationsdatum
01.05.2008
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 4/2008
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-007-9095-4

Weitere Artikel der Ausgabe 4/2008

Cancer Causes & Control 4/2008 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.